Therefore, a decrease in the SHBG level leads to an increase in circulating free sex hormones, which promotes the proliferation of mammary epithelial cells and inhibits cell apoptosis, thereby preventing the destruction of precancerous cells [51] and increasing the risk of postmenopausal breast cancer, especially ER-positive breast cancer. The gene discussed is SHBG; the disease is breast cancer.